openPR Logo
Press release

Emerging Predictive Biomarkers Market Driver 2025-2034: Rising Cancer Cases To Boost Predictive Biomarkers Market Growth

02-18-2025 07:50 AM CET | Health & Medicine

Press release from: The Business Research Company

Predictive Biomarkers Market Size

Predictive Biomarkers Market Size

How Is the Predictive Biomarkers Market Projected to Grow, and What Is Its Market Size?
In recent times, the size of the predictive biomarkers market has witnessed consistent growth. It is projected to expand from $20.05 billion in 2024 to $20.96 billion in 2025, with a compound annual growth rate (CAGR) of 4.5%. The growth observed in the past could be associated with factors such as the rise in research and development investments, the enhancement of healthcare infrastructure, collaborations between academic institutions and the industry, the increasing prevalence of cancer and genetic disorders, and the augmented utilization of biomarkers in the process of drug development.

The size of the predictive biomarkers market is predicted to experience consistent growth over the next few years, reaching $24.67 billion in 2029 with a compound annual growth rate (CAGR) of 4.2%. Reasons for this growth over the predicted period include the growing use of precision medicine, an increased focus on preventive healthcare, the rise in healthcare spending, larger investments in biomarker-based diagnostics, the expansion of biobanks and tissue depositories, and an increase in global health consciousness. Major trends noticed for the forecasted period comprise the incorporation of artificial intelligence in biomarker research, the evolution of non-invasive biomarker exams, progress in digital health tools based on biomarkers, strides forward in single-cell sequencing technologies, creation of real-time bio-sensing and tracking systems, and improvements in data integration bioinformatics tools.

What Are the Key Drivers Behind the Growth of the Predictive Biomarkers Market?
The predictive biomarkers market is anticipated to expand due to the increasing incidence of cancer. Cancer, known for its unchecked cell growth potentially leading to invasions and spreading to other body parts, is rising primarily as a result of aging populations, lifestyle transformations, and an increased exposure to hazardous elements such as tobacco, unwholesome diets, and pollutants from the environment. Predictive biomarkers play a critical role in cancer treatment by identifying patients who are likely to respond favourably to specific treatments, thereby facilitating personalized and efficient therapy. For example, a report from the International Agency for Research on Cancer (IARC), a specialized agency from France under the umbrella of the World Health Organization (WHO) concentrating on cancer research, stated in April 2024 that nearly 20 million new instances of cancer occurred and around 10 million cancer-related deaths were recorded in 2022. Additionally, the forecast indicates that the yearly new cancer cases count could escalate to 35 million by 2050, indicating a 77% surge compared to 2022. Hence, the increasing number of cancer cases will spur the growth of the predictive biomarkers market.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20595&type=smp

Who Are the Major Industry Players Fueling Predictive Biomarkers Market Expansion?
Major companies operating in the predictive biomarkers market are Johnson & Johnson Services Inc, F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens Healthcare GmbH, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Bio-Rad Laboratories Inc, QIAGEN GmbH, Almac Group Limited, ArcherDX Inc, Luminex Corporation, Guardant Health Inc, Meso Scale Diagnostics LLC, Myriad Genetics Inc, NanoString Technologies Inc, Fujirebio Inc, Asuragen Inc, Biognosys AG, Epigenomics AG, OncoCyte Corporation, Biomarker Technologies Inc

Who Are the Major Industry Players Fueling Market Expansion?
Leading corporations in the predictive biomarkers market are striving to hasten the progression of biomarker innovation via state-of-the-art technology, like AI-guided biomarker detection, in order to uphold competitiveness by providing more personalized and efficient treatments at a quicker pace. The analysis of vast, multifaceted datasets is made possible by AI-guided biomarker discovery, leading to the identification of predictive biomarkers that may go unnoticed through conventional methods. For example, in July 2024, Scipher Medicine, Inc., a precision immunology firm based in the US, initiated PRoBeNet (Predictive Response Biomarkers using Network Medicine) with the objective of speeding up the creation of predictive response biomarkers for intricate diseases by employing AI and network biology. PRoBeNet detects biomarkers of therapy response by amalgamating therapy-targeted proteins and disease-specific molecular signatures. Its validation extends to autoimmune diseases like rheumatoid arthritis, ulcerative colitis, and Crohn's disease and can be used for other intricate diseases and drug development stages.

How Is the Segmentation of the Predictive Biomarkers Market Defined?
The predictive biomarkers market covered in this report is segmented -

1) By Indication: Cancer, Metabolic Disease, Cardiovascular Disorder, Immunological Disorder, Other Indications
2) By Application: Screening, Analysis, Diagnosis, Prediction, Monitoring
3) By End User: Diagnostic Centers, Contract Research Organizations, Academic Research Institutes, Pharms And Biotech Companies, Other End Users

Subsegments:
1) By Cancer: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer, Leukemia And Lymphoma, Melanoma, Pancreatic Cancer, Kidney Cancer, Head And Neck Cancer
2) By Metabolic Disease: Type 1 and Type 2 Diabetes, Obesity, Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease (NAFLD), Dyslipidemia, Insulin Resistance
3) By Cardiovascular Disorder: Atherosclerosis, Coronary Artery Disease, Heart Failure, Myocardial Infarction (Heart Attack), Arrhythmia, Hypertension, Stroke, Peripheral Arterial Disease
4) By Immunological Disorder: Autoimmune Diseases, Inflammatory Bowel Disease (IBD), Multiple Sclerosis, Psoriasis, Allergic Diseases, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Immunodeficiency Disorders
5) By Other Indications: Neurological Disorders, Infectious Diseases, Renal Diseases, Osteoarthritis, Genetic Disorders, Respiratory Disorders

Pre-Book Your Report Now For A Swift Delivery:
https://www.thebusinessresearchcompany.com/report/predictive-biomarkers-global-market-report

What Is the Leading Region in the Predictive Biomarkers Market?
North America was the largest region in the predictive biomarkers market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Is Covered In The Predictive Biomarkers Global Market Report?

- Market Size Analysis: Analyze the predictive biomarkers Market Size by key regions, countries, product types, and applications.
- Market Segmentation Analysis: Identify various subsegments within the predictive biomarkers market for effective categorization.
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.
- Market Contribution: Evaluate contributions of different segments to the overall predictive biomarkers market growth.
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.
- Industry Challenges: Analyze challenges and risks affecting the predictive biomarkers market.
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20595

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Emerging Predictive Biomarkers Market Driver 2025-2034: Rising Cancer Cases To Boost Predictive Biomarkers Market Growth here

News-ID: 3873166 • Views:

More Releases from The Business Research Company

Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Forecast Report
Unlocking Opportunities in the Tyrosine Kinase Inhibitors Market: 2025-2034 Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Tyrosine Kinase Inhibitors Industry Market Size Be by 2025? The market for tyrosine kinase inhibitors has seen robust growth in recent times. The market is predicted to expand from $58.03 billion in 2024 to $62.66 billion in 2025, marking a compound annual growth rate (CAGR) of
Sustained Release Excipients Market Advances With Product Innovation Industry Trends Gaining Momentum in the Global Sustained Release Excipients Market
Sustained Release Excipients Market Advances With Product Innovation Industry Tr …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Sustained Release Excipients Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size of sustained release excipients has seen significant growth. It's projected to increase from $1.4 billion in 2024 to $1.51 billion in 2025, exhibiting a Compound Annual Growth Rate
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therapeutics Market Driving Market Acceleration in the RNA Targeting Small Molecules Therapeutics Industry, 2025
Surge In Cancer Cases Fuels Expansion Of The RNA-Targeting Small Molecule Therap …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the RNA Targeting Small Molecules Therapeutics Market Size By 2025? In recent years, the market size of RNA targeting small molecules therapeutics has witnessed substantial growth. The market, which is estimated to be worth $6.1 billion in 2024, is projected to increase to $7.83 billion in
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as a Core Driver of the Remicade Biosimilar Market in 2025
Surge In Autoimmune Diseases Fuels Remicade Biosimilar Market Growth Emerges as …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Is the Expected CAGR for the Remicade Biosimilar Market Through 2025? In recent times, we've seen significant expansion in the remicade biosimilar market. Projected growth from 2024's $3.95 billion to $4.89 billion in 2025 indicates a compound annual growth rate (CAGR) of 23.8%. This rise during the historic

All 5 Releases


More Releases for Predictive

Predictive Maintenance Market to Hit USD 111.30 Billion By 2030, Boosting Equipm …
✎ Market Overview: The global Predictive Maintenance Market is experiencing rapid growth, driven by the increasing adoption of Industry 4.0 technologies and a strong focus on cost efficiency and operational productivity. Predictive maintenance (PdM) uses data analysis tools and techniques to detect anomalies in equipment and predict possible failures, allowing for timely maintenance that minimizes downtime and extends asset life. As industrial sectors shift toward digital transformation, the use of artificial
Emerging Trends Influencing The Growth Of The Predictive Maintenance Market: Enh …
The Predictive Maintenance Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Predictive Maintenance Market? The market size of predictive maintenance has experienced significant growth in the past few years. The projections suggest an increase from $9.3 billion in 2024
Manufacturing Predictive Analytics Market to Reach USD 2.52 Billion |Revolutioni …
Advent of Industry 4.0, evolution of IIoT, and rise in operational efficiencies from big data initiatives fuel the growth of the global manufacturing predictive analytics market. On the other hand, dearth of skilled workforce and threat of cyber-attack restrain the growth to some extent. Nevertheless, development of smart data-driven organizations and interference of artificial intelligence (AI) into manufacturing are expected to create multiple opportunities in the near future. The report
Predictive Maintenance Market to Grow at 28.8% CAGR | Predictive Maintenance Pio …
According to a recent report published by Allied Market Research, titled, "Predictive maintenance market by component, technique, deployment type, stakeholder, and industry vertical: opportunity analysis and industry forecast, 2020-2027,"the global predictive maintenance market size was valued at $4,331.56 million in 2019, and is projected to reach $31,965.49 million by 2027, growing at a CAGR of 28.8% from 2020 to 2027. On the basis of deployment model, the on-premise segment
Healthcare Predictive Analytics Market Size to Hit $74.62 Billion by 2028 | Heal …
Market Overview: According to our experience research team, Healthcare Predictive Analytics Market was valued at USD 20.16 Billion in 2021, and the global Healthcare Predictive Analytics industry is projected to reach a value of USD 74.62 Billion by 2028, at a CAGR of 27% during the forecast period 2022-2028 Vantage Market Research is a collection of market research studies on several industries, such as Chemicals, semiconductors & Electronics, Food & Beverages Technology,
Demand for Predictive Maintenance Management Is High In Predictive Maintenance M …
𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝘃𝗲 𝗠𝗮𝗶𝗻𝘁𝗲𝗻𝗮𝗻𝗰𝗲 𝗠𝗮𝗿𝗸𝗲𝘁 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗣𝗿𝗼𝘀𝗽𝗲𝗰𝘁𝘀 𝗳𝗿𝗼𝗺 𝟮𝟬𝟮𝟭 𝘁𝗼 𝟮𝟬𝟮𝟳 The global Predictive Maintenance market is estimated to account for US$ 17.7 Billion By 2026. Predictive maintenance systems are designed to assist manufacturing companies in determining the condition of their on-site equipment so as to gauge when regular maintenance ought to be done. This system promises significant cost savings since tasks are done only when necessary, thereby aiding in growth of the predictive